ORIGINAL ARTICLE

Analysis of nerve growth factor serum levels in psoriasis vulgaris patients

Riana Novatina E. Pangaribuan , Imam B. Putra, Kristo A. Nababan

Riana Novatina E. Pangaribuan
Postgraduate of Dermatovenerology, Faculty of Medicine, Sumatera Utara University, Medan, North Sumatera, Indonesia. Email: nvpangaribuan@gmail.com

Imam B. Putra
Department of Dermatovenerology, Faculty of Medicine, Sumatera Utara University, Medan, North Sumatera, Indonesia

Kristo A. Nababan
Department of Dermatovenerology, Faculty of Medicine, Sumatera Utara University, Medan, North Sumatera, Indonesia
Online First: August 01, 2019 | Cite this Article
Novatina E. Pangaribuan, R., B. Putra, I., A. Nababan, K. 2019. Analysis of nerve growth factor serum levels in psoriasis vulgaris patients. Bali Medical Journal 8(2). DOI:10.15562/bmj.v8i2.1446


Background: Psoriasis is a complex chronic inflammatory skin disease with multifactorial mechanism affected by immunological, genetic, environmental and nervous system factors which its mechanism is still unknown. The involvement of nervous system in psoriasis is ruled by nerve growth factor (NGF). Increased levels of NGF serum are expected occurring in psoriasis vulgaris.

Aim: To determine the differences between NGF serum levels in psoriasis vulgaris patients and controls

Methods: This study is an analytic study with cross sectional design involving 30 psoriasis vulgaris patients and 30 healthy controls. Diagnosis of psoriasis vulgaris was made based on history and clinical examination; we conducted blood sampling and measurement of NGF serum level to the patients and controls. The differences between NGF serum levels in psoriasis vulgaris patients and controlled is analyzed by independent-t test. This research approved by the health research ethics committee of the Faculty of Medicine of Sumatra Utara University/ H. Adam Malik  Medan General Hospital.

Results: In this study, we found the mean NGF serum level of female psoriasis vulgaris patients (810.30 ± 299.97 pg/ml)  was higher compared to male (806.70 ± 256.04 pg/ml).  The mean NGF serum of psoriasis vulgaris patients were highest on ages group 15 – 23 years (930.14 ± 69.03 pg/ml). The mean NGF serum level of psoriasis vulgaris without family history (875.38 ± 203.91 pg/ml) was higher compared to patient with a maternal history (600.87 ± 387.45 pg/ml) and paternal history (477.88 ± 406.97 pg/ml). The mean NGF serum level in the psoriasis vulgaris group (808.38 ± 272.48 pg/ml) was higher compared to the control group (524.92 ± 281.22 pg/ml) dengan with p=0.0001.

Conclusion: There were significant differences in NGF serum levels between psoriasis vulgaris patients and control.

References

Raychaudhuri SP, Jiang WY, Farber EM. Psoriatic keratinocytes express high levels of nerve growth factor. Acta Dermatol Venereol.1998;78:84–6

Botchkarev VA, Yaar M, Peters EMJ, Raychaudhuri SP, Botchkareva NV, Marconi A, et al. Neurotrophins in Skin Biology and Pathology. The Society for Investigative Dermatology. 2006; 126: 1719–27. doi:10.1038/sj.jid.5700270.

Raychaudhuri SP, Jiang WY, Raychaudhuri SK. Revisiting the Koebner Phenomenon Role of NGF and Its Receptor System in the Pathogenesis of Psoriasis. The American Journal of Pathology. 2008;172(4):961-71. doi: 10.2353/ajpath.2008.070710

Sofroniew MF, Howe CL, Mobley WC. Nerve Growth Factor Signaling, Neuroprotection and Neural Repair. Annu. Rev. Neurosci. 2001; 24:1217–281.

Raychaudhuri SP, Raychaudhuri SK. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Progress in Brain Research. 2004;146:433-7. doi: 10.1016/S0079-6123(03)46027-5

Lang UE, Gallinat J, Danker-Hopfe D, Bajbouj M, Hellweg R. Nerve Growth Factor serum concetrations in healthy human volunteers: physiological variance and stability. Neuroscience Letters. 2001;13-16

Serrano T, Lorigados LC, Armenteros S. Nerve growth factor levels in normal human sera. Neuro report 8. 1996;179-181

Herbruggen OS, Litzke J, Zingler C, Hoppner J, Vorchow JC, Hellweg R, et al. Maternal nerve growth factor serum levels in the perinatal period. J Reprod Immunol. 2007;74(1-2):170-3.

Vinod CA, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. Journal of Autoimmunity. 2010;34:314-321. doi:10.1016/j.jaut.2009.12.001

Joachim RA, Kuhlmei A, Dinh Q, Handjiski B, Fischer T, Peters EMJ,et al. Neuronal plasticity of the “brain–skin connection”: stress-triggered up-regulation of neuropeptides in dorsal root ganglia and skin via nerve growth factor dependent pathways. J Mol Med. 2007;85:1369-78. doi:10.1007/s00109-007-0236-8


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0